Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism

Annals of Internal Medicine

Volumn 131, Issue 5, 1999, Pages 348-351

  Hussein, Wiam I ^a   Green, Ralph ^b   Jacobsen, Donald W ^c   Faiman, Charles ^c  

^a Saad Medical Center   (Saudi Arabia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; LEVOTHYROXINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033533444     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-5-199909070-00005     Document Type: Article

References (20)

1. Vanhaelst L, Neve P, Chailly P, Bastenie PA. Coronary artery disease in hypothyroidism. Observation in clinical myxedema. Lancet. 1967;2:800-2.
2. Steinberg AD. Myxedema and coronary artery disease - a comparative autopsy study Ann Intern Med. 1968;68:338-44.
3. Grytting G, Salvesen HA. Thyrotoxicosis and myocardial infarction. Acta Med Scand. 1957;57:169-71.
4. Mason RL, Hunt HM, Hurxthal L Blood cholesterol values in hyperthyroidism and hypothyroidism - their significance. N Engl J Med. 1930;203:1273-8.
5. Williams GH, Braunwald E. Endocrine and nutritional disorders and heart disease. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine Philadelphia: Saunders: 1984:1722-47.
6. Saito I, Saruta T. Hypertension in thyroid disorders. Endocrinol Metab Clin North Am. 1994;23:379-86.
7. Streeten DH, Anderson GH Jr, Howland T, Chiang R, Smulyan H. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension. 1988;11:78-83.
8. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-55.
9. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 1996;27:517-27.
10. Boushey C, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049-57.
11. Refsum H, Ueland P, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31-62.
12. Finkelstein JD. Methionine metabolism in mammals. Journal of Nutrition and Biochemistry. 1990;1:228-37.
13. Lindenbaum J, Klipstein FA. Folic acid clearance and serum folate levels in patients with thyroid disease. J Clin Pathol. 1964;17:666-70.
14. Nair CP, Viswanathan G, Noronha J. Folate-mediated incorporation of ring-2-carbon of histidine into nucleic acids: influence of thyroid hormone. Metabolism. 1994;43:1575-8.
15. Green R, Chong YY, Jacobsen DW, Robinson K, Gupta M. Serum homocysteine is high in hypothyroidism: a possible link with coronary artery disease. Irish Journal of Medical Science. 1995;164(Suppl 15):27-8.
16. Jacobsen DW, Gatautis VJ, Green R, Robinson K, Savon SR, Secic M, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem, 1994;40:873-81.
17. Camp VM, Chipponi J, Faraj BA. Radioenzymatic assay for direct measurement of plasma pyridoxal 5′-phosphate. Clin Chem. 1983;29:642-4.
18. Nedrebo BG, Ericsson UB, Nygard O, Refsum H, Ueland PM, Aakvaag A, et al. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism. 1998;47:89-93.
19. Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effects of levothyroxine therapy. Arch Intern Med. 1990;150: 2097-100.
20. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775-81.